��������

The Pfizer-BioNTech coronavirus vaccine appears to be safe and effective in children between 5 and 11 years old, according to the companies, with a dose that’s a third of the amount given to teens and adults. The two shots given 21 days apart also brought on side effects that were “generally comparable” to those experienced by 16- to 25-year-olds, Pfizer officials said in a statement released Monday. The companies plan on submitting their data to the U.S. Food and Drug Administration and other regulatory agencies before the winter. The announcement lifts a weight that has been sitting on some parents’ shoulders as pediatric COVID-19 cases skyrocket across the country. Since July, coronavirus infections among kids have risen by about 240%, according to Pfizer officials.